Evidence map›Paper›PMID 35024563›Full record

ArticleAccess microbiology2021

Julie Tang, Dimitri Kornblum, Nagisa Godefroy, Gentiane Monsel, Jérome Robert, Eric Caumes, Valérie Pourcher, Elise Klement-Frutos

Open access · goldAbstract readCase Reports
In one paragraph

Article in Access microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Pathogens (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Julie TangSorbonne Université, Assistance Publique-Hôpitaux de Paris, Service des Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, 75013-Paris, France.ORCID https://orcid.org/0000-0002-6182-8704
Dimitri KornblumSorbonne Université, Assistance Publique-Hôpitaux de Paris, Service des Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, 75013-Paris, France.
Nagisa GodefroySorbonne Université, Assistance Publique-Hôpitaux de Paris, Service des Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, 75013-Paris, France.
Gentiane MonselSorbonne Université, Assistance Publique-Hôpitaux de Paris, Service des Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, 75013-Paris, France.
Jérome RobertSorbonne Université, Assistance Publique-Hôpitaux de Paris, Service de Bactériologie et d'Hygiène hospitalière, Hôpital Pitié-Salpêtrière, 75013-Paris, France.
Eric CaumesSorbonne Université, Assistance Publique-Hôpitaux de Paris, Service des Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, 75013-Paris, France.
Valérie PourcherSorbonne Université, Assistance Publique-Hôpitaux de Paris, Service des Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, 75013-Paris, France.
Elise Klement-FrutosSorbonne Université, Assistance Publique-Hôpitaux de Paris, Service des Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, 75013-Paris, France.
Sorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCASE REPORT: We report here the first case of a quinquagenarian patient with a history of AIDS and fungic endocarditis, who was diagnosed with a nosocomial thrombophlebitis in the right jugular vein caused by

conclusionThe lack of consensus relative to the management of septic thrombophlebitis precludes the validation of a specific treatment for the condition. Our results suggest that a combination that includes removal of the medical device is needed. A total of 6 weeks of antibiotherapy should be applied, starting with 2 weeks of vancomycin or a combination of antibiotitherapy with daptomycin in order to reduce the bacterial load and avoid resistance. Six weeks of anticoagulation therapy is effective.

Indexed as

Corynebacteriummultidrug resistanceseptic thrombophlebitis

Identifiers

PMID35024563
PMCPMC8749143
OpenAlexW4200221903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.